Cel Sci CVM
NYSE CVM
$1.47 +0.01 (+0.68%)
As of: Aug 21, 2026 · 12:59 PM EDT

Cel Sci (CVM) FCF Margin (QoQ) (2011)

Cel Sci (CVM) FCF Margin (QoQ) (2011) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.59 Bn 131.73 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.21 Bn 78.22 Bn 3.93 Bn
3 Argenx Se 65.65 Bn 60.47 Bn 1.37 Bn
4 Moderna 57.67 Bn 52.53 Bn 52.00 Mn
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn
7 BioNTech SE 27.90 Bn 9.51 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.45 Bn -
10 Cel Sci 2.18 Mn -4.36 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2011 654,112.00